Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine
— Publication includes complete data for all participants (n=39) up to week 72, further demonstrating durable and tolerable expression of DMAbs — Effective target binding and confirmed functional activity through week 72 — No immune rejection of theDMAbs detected across ~1,000 blood samples — Most common side effects were mild, temporary injection site reactions such […]